Ignite Creation Date:
2024-05-06 @ 1:48 PM
Last Modification Date:
2024-10-26 @ 1:20 PM
Study NCT ID:
NCT04124965
Status:
COMPLETED
Last Update Posted:
2023-09-05
First Post:
2019-10-11
Brief Title:
A Study to Investigate the Long-term Safety Tolerability and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma